Pediatrix Medical Group, Inc.

MD · NYSE · Stock · Healthcare
$27.49
+1.70% today
Delayed price,

What Pediatrix Medical Group does

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Key facts

Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$2.23B
P/E (ttm)
12.9
Forward P/E
11.3
Dividend yield
0.00%
Beta
0.61
Profit margin
9.0%
Employees
4,280
Headquarters
Sunrise, FL, United States
Exchange
NYSE

Performance

1 Month
+6.0%
3 Months
+5.2%
6 Months
+19.2%
1 Year
+67.1%
5 Years
+11.9%
$16.0252-week range$27.94
Biggest setback — last 12 months
-21.9%
24 Nov 2025 → 16 Feb 2026
Fell from $24.09 to $18.82 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+67.1%
13 Oct 2025 → 15 Oct 2026
Ran from $16.45 to $27.49 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$24.85 (-9.6%)$27.49$30.41 (+10.6%)
3 Months$23.08 (-16.0%)$27.49$32.74 (+19.1%)
6 Months$21.47 (-21.9%)$27.49$35.20 (+28.0%)
12 Months$19.38 (-29.5%)$27.49$38.99 (+41.8%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 35.0%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Sold 6,000 shares at $26.82 — Linynsky Laura A, Director · 2026-09-14
Sold 18,500 shares at $26.62 — Young Sylvia Jean, Director · 2026-08-18
Acquired 472 shares at $26.50 — McEachin Thomas, Director · 2026-08-14
Acquired 472 shares at $26.50 — Weis Shirley A, Director · 2026-08-14
Acquired 472 shares at $26.50 — Starcher John M. Jr., Director · 2026-08-14
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.